Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis
about
Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitisNeuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.Influence of Circulating Endothelin-1 and Asymmetric Dimethylarginine on Whole Brain Circulation Time in Multiple Sclerosis.[Immunoadsorption for steroid-unresponsive multiple sclerosis-relapses: clinical data of 14 patients].Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders.The blood-brain barrier in health and disease.Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people.Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier functionVenous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysisSera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrierCognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.Neurofascin as a novel target for autoantibody-mediated axonal injuryComplement is activated in progressive multiple sclerosis cortical grey matter lesions.Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.A dynamic in vivo-like organotypic blood-brain barrier model to probe metastatic brain tumors.Differential receptor-mediated drug targeting to the diseased brain.Relapsing and progressive forms of multiple sclerosis: insights from pathology.T Cells-Protective or Pathogenic in Alzheimer's Disease?Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.Bovine serum albumin promotes IL-1beta and TNF-alpha secretion by N9 microglial cells.Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study.Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.IFN-γ promotes transendothelial migration of CD4+ T cells across the blood-brain barrier.Transient peripheral immune response and central nervous system leaky compartmentalization in a viral model for multiple sclerosis.Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions.Age-associated white matter lesions: the MRC Cognitive Function and Ageing Study.Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.Dynamic Changes in Brain Mesenchymal Perivascular Cells Associate with Multiple Sclerosis Disease Duration, Active Inflammation, and Demyelination.Age-associated changes in the blood-brain barrier: comparative studies in human and mouse.Lesion enhancement diminishes with time in primary progressive multiple sclerosis.Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis.Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis.High-mobility group box 1 in multiple sclerosis.Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination.Studying the blood-brain barrier will provide new insights into neurodegeneration - Yes.
P2860
Q28588370-D514AEEB-47E6-4385-9371-1F6B15F9B8D4Q30576477-46B51671-D5C3-4B3F-BC35-C8AA7D741BAFQ30960900-6ADAC2A8-74FD-49C1-BC58-862ACBA3F7C1Q33773354-186AD936-2F66-453A-8E8C-9F14CFDE37C8Q33930630-9AA799F5-A163-49E7-A416-7B212F59C046Q34295012-E88DE8F5-7D7D-4139-8049-5F0B9E49AD72Q34304978-84163CFE-A2CE-4AF6-A466-AD0D8B197D90Q34320420-D9302333-C4D8-4162-9DF8-4CCBACA39538Q34406773-E858C60C-A83F-443D-82B7-391694549FAFQ34667556-193D5F86-B041-4723-B6FE-016598A4F7EBQ34750423-0A0CF992-7BFB-4610-BD85-0CC21D6B9E82Q35136280-EB97E0ED-81EC-41DF-B2B7-390E03B22B42Q35529255-0C83758A-AD03-4813-92E6-D6669B5D2014Q35578146-8B351F7B-18EE-4048-9435-1EDCFDCA69CAQ36228999-DEAA6BF8-576D-4341-95A7-B4809FB6A404Q37031176-A526746B-CCF1-4182-AB7E-1FF32196662AQ37343069-0941E93D-B7A6-43A8-BD24-C47D31AEB83CQ37405615-F8B18860-0D4B-4D55-AA3E-A0D7E3404474Q37425213-8706006B-2494-438C-9DE9-9182C36C1833Q38203770-5034B68A-2C4B-4021-8358-2E2AA6165A19Q38469322-5F0EAF06-EFA3-48F8-82EE-A6BBB3433818Q38655974-DF5E4B3B-C500-4C91-8781-EAB08C42F036Q39810048-16ACB212-4097-431E-A8A9-C24814F19F3FQ39876276-12CB6D5B-9B31-4B0A-93ED-C09B945F7FE2Q42433959-33CC63B7-F900-4276-9A66-75027B2A9B63Q42511998-46C224F6-B801-47C5-9B7D-70E3E8F3C16FQ43826334-5930EB00-8340-47AA-A5AD-8004024193A5Q44602716-323A2185-B9C3-45BE-80A1-C51375DA98A5Q44710137-57C5C27E-4759-4783-AD45-19886CA47368Q48098195-DD3AE9D9-66AD-4D93-8D35-68744AC2E843Q48100073-A8146E89-75B8-40D7-975B-E3ADA5C7BE1EQ48217866-AA147C06-2E71-408C-B548-45CE37055206Q48283891-FAA3E55B-AD91-42B6-90C8-5559D2BE32D9Q48366273-43E2C431-986E-47F6-9180-99236737FC80Q48658707-296FB535-17E6-4111-BCDF-057ECA7E39EBQ53210919-0F64C3E3-C187-4F2C-AFC5-706AF03074BDQ54229364-02D2743F-0C52-4EE8-AD85-116BAEC6CB36Q55628626-D444238A-8E51-4670-B5E5-ED1CEEF25F0C
P2860
Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Persistent endothelial abnorma ...... progressive multiple sclerosis
@ast
Persistent endothelial abnorma ...... progressive multiple sclerosis
@en
Persistent endothelial abnorma ...... progressive multiple sclerosis
@nl
type
label
Persistent endothelial abnorma ...... progressive multiple sclerosis
@ast
Persistent endothelial abnorma ...... progressive multiple sclerosis
@en
Persistent endothelial abnorma ...... progressive multiple sclerosis
@nl
prefLabel
Persistent endothelial abnorma ...... progressive multiple sclerosis
@ast
Persistent endothelial abnorma ...... progressive multiple sclerosis
@en
Persistent endothelial abnorma ...... progressive multiple sclerosis
@nl
P2093
P2860
P921
P3181
P1476
Persistent endothelial abnorma ...... progressive multiple sclerosis
@en
P2093
P2860
P3181
P356
10.1111/J.1365-2990.2006.00781.X
P407
P50
P577
2007-02-01T00:00:00Z